Valuation: Illumina, Inc.

Market Cap 28.67B 25.16B 23.43B 21.55B 40.39B 2,739B 41.09B 278B 109B 1,358B 108B 105B 4,693B P/E 2026 *
40.4x
P/E 2027 * 33.3x
Enterprise Value 29.16B 25.59B 23.83B 21.92B 41.09B 2,786B 41.79B 283B 111B 1,382B 109B 107B 4,773B EV / Sales 2026 *
6.38x
EV / Sales 2027 * 5.89x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day+1.80%
1 week+0.12%
Current month+9.63%
1 month+6.44%
3 months+51.88%
6 months+28.63%
Current year+46.97%
1 week 187.67
Extreme 187.67
199.14
1 month 174.78
Extreme 174.78
199.14
Current year 112.65
Extreme 112.65
199.14
1 year 88
Extreme 88
199.14
3 years 68.7
Extreme 68.7
199.14
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer 55 2025-05-28
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Director

167 0.0001%
6/30/26 Free

Director

142 0.0001%
6/30/26
Corvex Management LP
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+0.12%+75.44%+0.17% 28.67B
+2.98%+10.08%+18.82%+2.56% 208B
+2.15%+11.70%-1.47%-23.11% 138B
+2.20%+4.07%-26.25%+11.57% 126B
+2.04%+7.46%-56.15%-10.21% 67.64B
+0.99%-0.75%+6.92%+0.21% 47.81B
+1.01%+4.09%-24.96%-31.74% 45.03B
+1.96%+5.50%+17.26%+11.20% 38.94B
+3.75%+4.28%+26.76%+34.12% 36.45B
+2.30%+5.93%-24.17%-7.06% 29.29B
Average +2.16%+1.32%+1.22%-1.23% 76.6B
Weighted average by Cap. +2.31%+1.49%-1.42%-2.40%

Financials

2026 *2027 *
Net sales 4.57B 4.01B 3.74B 3.44B 6.44B 437B 6.55B 44.31B 17.34B 217B 17.16B 16.79B 748B 4.83B 4.24B 3.95B 3.63B 6.81B 462B 6.92B 46.84B 18.33B 229B 18.14B 17.74B 791B
Net income 724M 635M 591M 544M 1.02B 69.13B 1.04B 7.02B 2.75B 34.28B 2.72B 2.66B 118B 871M 765M 712M 655M 1.23B 83.26B 1.25B 8.45B 3.31B 41.29B 3.27B 3.2B 143B
Net Debt 492M 431M 402M 369M 693M 46.96B 704M 4.77B 1.87B 23.29B 1.85B 1.81B 80.46B -222M -194M -181M -167M -312M -21.16B -317M -2.15B -841M -10.5B -832M -814M -36.26B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
26-07-28 US$192.96 +1.84% 785,183
26-07-27 US$189.47 -2.38% 1,738,894
26-07-24 US$194.09 -1.41% 1,301,036
26-07-23 US$196.86 +3.14% 1,220,931
26-07-22 US$190.87 -0.86% 1,551,517
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
189.47USD
Average target price
172.53USD
Spread / Average Target
-8.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock